|
|||||
|
|
| 基于倾向性评分逆概率加权法的脉络膜黑色素瘤患者疗效评价研究 | |
| 引用本文： | 石丽娟,李丽,石福艳,周希彬,吴志鸿. 基于倾向性评分逆概率加权法的脉络膜黑色素瘤患者疗效评价研究[J]. 眼科新进展, 2023, 0(4): 308-312. DOI: 10.13389/j.cnki.rao.2023.0063 |
| 作者姓名： | 石丽娟 李丽 石福艳 周希彬 吴志鸿 |
| 作者单位： | 261053 山东省潍坊市，潍坊医学院临床医学院眼科学教研室（石丽娟，李丽）；100039 北京市，解放军总医院第三医学中心眼科医学部（石丽娟，李丽，周希彬，吴志鸿）；261053 山东省潍坊市，潍坊医学院公共卫生学院卫生统计学教研室（石福艳） |
| 摘 要： | 目的 在平衡组间基线变量后，评价放射治疗与手术联合放射治疗两种治疗方式对脉络膜黑色素瘤患者的疗效，分析脉络膜黑色素瘤患者的预后影响因素，为脉络膜黑色素瘤的有效诊疗提供参考依据。方法 对2000年1月至2019年12月在SEER数据库中登记的脉络膜黑色素瘤患者进行分析，采用倾向性评分逆概率加权法(IPTW)对放射治疗和手术联合放射治疗两组患者的基线特征进行平衡。结果 本研究共筛选脉络膜黑色素瘤患者5547例，其中接受放射治疗者4422例、接受手术联合放射治疗治疗者1125例。在接受放射治疗的4422例患者中，光束辐射(BR)组1155例，放射性植入物(RI)组2608例，放射性同位素(RIT)组659例。Log-rank检验结果显示，逆概率加权前后，放射治疗组患者的预后均高于手术联合放射治疗组(P<0.000 1)。多因素Cox回归分析结果显示，在控制了种族、性别、多灶性、是否为首要恶性肿瘤、婚姻状态、从诊断到治疗的时间、年龄、眼别、诊断确认、放射治疗方法等混杂因素后，与放射治疗组患者相比，手术放射治疗组患者的特异性死亡风险为HR=4.385(95%CI=3.542～5.428)。... |
| 关 键 词： | 脉络膜黑色素瘤 逆概率加权 疗效 生存分析 |
Efficacy evaluation of choroidal melanoma based on propensity score inverse probability of treatment weighting method |
|
| SHI Lijuan1,' target="_blank" rel="external">2,LI Li1,' target="_blank" rel="external">2,SHI Fuyan3,ZHOU Xibin2,WU Zhihong2. Efficacy evaluation of choroidal melanoma based on propensity score inverse probability of treatment weighting method[J]. Recent Advances in Ophthalmology, 2023, 0(4): 308-312. DOI: 10.13389/j.cnki.rao.2023.0063 | |
| Authors: | SHI Lijuan1,' target=" _blank" rel=" external" >2,LI Li1,' target=" _blank" rel=" external" >2,SHI Fuyan3,ZHOU Xibin2,WU Zhihong2 |
| Affiliation: | 1.Department of Ophthalmology,School of Clinical Medicine,Weifang Medical University，Weifang 261053,Shandong Province，China2.Senior Department of Ophthalmology,the Third Medical Center of PLA General Hospital,Beijing 100039,China3.Department of Health Statistics,School of Public Health,Weifang Medical University,Weifang 261053,Shandong Province，China |
| Abstract: | Objective To evaluate the efficacy of radiotherapy and surgery combined with radiotherapy on choroidal melanoma and analyze the prognostic factors of choroidal melanoma upon balancing the inter-group baseline variables, giving a reference for effective diagnosis and treatment of choroidal melanoma. Methods Patients with choroidal melanoma enrolled from the Surveillance, Epidemiology, and End Results database from January 2000 to December 2019 were analy zed. Propensity score inverse probability of treatment weighting (IPTW) was used to balance the baseline characteristics of patients in the radiotherapy group and combined surgery and radiotherapy group. Results A total of 5547 patientswith choroidal melanoma were selected in this study, including 4422 patients who received radiotherapy and 1125 patients who received surgery combined with radiotherapy. Among the 4422 patients who received radiotherapy, 1155 were divided into the radioactive beam irradiation (BR) sub-group, 2608 were divided into the radioactive implant (RI) sub-group, and 659 were divided into the radioactive isotope (RIT) sub-group. The log-rank test showed that before and after IPTW, the prognosis of patients in the radiotherapy group was higher than that in the combined surgery and radiotherapy group (both P<0.000 1). The multivariate Cox regression analysis showed that after controlling the confounding factors such as race, gender, multifocality, primary malignant tumor, marital status, time from diagnosis to treatment, age, eye side, diagnosis confirmation and radiotherapy method, compared to patients in the radiotherapy group, the specific mortality risk in the combined surgery and radiotherapy group was HR=4.385 (95% CI=3.542-5.428). Compared to patients under 50 years old, the specific mortality risk of patients aged 50-59 years, 60-69 years, 70-79 years and ≥80 years was HR=3.083 (95% CI=0.825-4.238), HR=4.045 (95% CI=2.955-5.532), HR=4.512 (95% CI=3.115-6.529), and HR=6.877 (95% CI=4.151-11.398), respectively. Compared to patients with only 1 malignant tumor, the specific mortality risk of patients with 2 and more than 2 malignant tumors was HR=0.698 (95% CI=0.449-2.944) and HR=0.538 (95% CI=0.317-0.913), respectively. Patients who waited longer than one month from diagnosis to treatment had a risk ratio of 2.732 to 4.154. The log-rank test results showed no significant difference in the survival curves of patients in the BR, RI and RIT sub-groups of the radiotherapy group before and after IPTW (all P>0.05). Conclusion The long-term efficacy of radiotherapy is better than that of surgery combined with radiotherapy. Age, single lesion, time from diagnosis to treatment, and treatment methods, which can increase the risk of death in patients with choroidal melanoma, are independent influencing factors on the prognosis of choroidal melanoma patients. |
| Keywords: | choroidal melanoma inverse probability of treatment weighting efficacy survival analysis |
| 点击此处可从《眼科新进展》浏览原始摘要信息 | |
| 点击此处可从《眼科新进展》下载免费的PDF全文 | |